Combined hormone therapy and cardiovascular, VTE risk

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1597, 2007-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combined hormone therapy and cardiovascular, VTE risk

Reactions Weekly, Vol. 1, Iss. 1161, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Cardiovascular Pharmacology of Hormone Replacement Therapy

By Rosano G.M.C. Panina G.

Drugs & Aging, Vol. 15, Iss. 3, 1999-09 ,pp. : 219-234

Adis International

Access to resources Recommend Favorite

Cardiovascular Disease Risk and Hormone Replacement Therapy (HRT): A Review Based on Randomised, Controlled Studies in Postmenopausal Women

Current Medicinal Chemistry, Vol. 7, Iss. 5, 2000-05 ,pp. : 499-517

Bentham Science Publishers

Access to resources Recommend Favorite

Risk of VTE with Ortho Evra?

Reactions Weekly, Vol. 1, Iss. 1092, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Ximelagatran reduces risk of VTE

Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite